Doxorubicin hydrochloride and Clostridium colitis - a phase IV clinical study of FDA data

Summary:

Clostridium colitis is reported as a side effect among people who take Doxorubicin hydrochloride (doxorubicin hydrochloride), especially for people who are female, 2-9 old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Nausea.

The phase IV clinical study analyzes which people have Clostridium colitis when taking Doxorubicin hydrochloride. It is created by eHealthMe based on reports of 25,305 people who have side effects when taking Doxorubicin hydrochloride from the FDA, and is updated regularly.

What is Doxorubicin hydrochloride?

Doxorubicin hydrochloride has active ingredients of doxorubicin hydrochloride. eHealthMe is studying from 25,343 Doxorubicin hydrochloride users. Check the latest studies of Doxorubicin hydrochloride.

What is Clostridium colitis?

Clostridium colitis (inflammation of colon by clostridium difficile bacteria infection) is found to be associated with 240 drugs and 503 conditions by eHealthMe. Check the latest studies of Clostridium colitis.



On Jul, 02, 2026

25,305 people reported to have side effects when taking Doxorubicin hydrochloride.
Among them, 18 people (0.07%) have Clostridium colitis.

Could Doxorubicin hydrochloride cause Clostridium colitis?

Among these 18 people:

How long have people been on Doxorubicin hydrochloride when they have Clostridium colitis? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Clostridium colitis when taking Doxorubicin hydrochloride? *

  • female: 77.78 %
  • male: 22.22 %

What is the age of people who have Clostridium colitis when taking Doxorubicin hydrochloride? *

  • 0-1: 0.0 %
  • 2-9: 56.25 %
  • 10-19: 6.25 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 6.25 %
  • 60+: 31.25 %

What are other drugs people take besides Doxorubicin hydrochloride? *

  1. Cyclophosphamide: 15 people, 83.33%
  2. Etoposide: 9 people, 50.00%
  3. Methylprednisolone: 8 people, 44.44%
  4. Topotecan Hydrochloride: 6 people, 33.33%
  5. Ondansetron: 5 people, 27.78%
  6. Prednisone: 3 people, 16.67%
  7. Prednisolone: 3 people, 16.67%
  8. Vincristine Sulfate: 2 people, 11.11%
  9. Topotecan: 2 people, 11.11%
  10. Metronidazole: 2 people, 11.11%

What are other side effects people have besides Clostridium colitis? *

  1. Dehydration (dryness resulting from the removal of water): 9 people, 50.00%
  2. Diarrhea: 7 people, 38.89%
  3. Nausea And Vomiting: 5 people, 27.78%
  4. Pleural Effusion (water on the lungs): 3 people, 16.67%
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 16.67%
  6. Febrile Neutropenia (fever with reduced white blood cells): 2 people, 11.11%
  7. Ascites (accumulation of fluid in the abdominal cavity): 2 people, 11.11%
  8. Thrombocytopenia (decrease of platelets in blood): 2 people, 11.11%
  9. Disease Progression: 2 people, 11.11%
  10. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 2 people, 11.11%

What are the existing conditions these people have? *

  1. Neuroblastoma (a cancer that forms in your nerve tissue): 8 people, 44.44%
  2. Nausea (feeling of having an urge to vomit): 8 people, 44.44%
  3. Refractory Cancer (cancer that has not responded to treatment): 7 people, 38.89%
  4. Recurrent Cancer (repeated cancer): 5 people, 27.78%
  5. Nausea And Vomiting: 5 people, 27.78%
  6. Ovarian Cancer (cancer of ovary): 1 person, 5.56%
  7. Lymphoma (cancer that begins in immune system cells): 1 person, 5.56%
  8. Ewing's Sarcoma (malignant small, round, blue cell tumour): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Doxorubicin hydrochloride and have Clostridium colitis?

- Check whether Clostridium colitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Doxorubicin hydrochloride:

Clostridium colitis treatments and more:

How severe was Clostridium colitis and when was it recovered:

Expand to all the drugs that have ingredients of doxorubicin hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Doxorubicin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Clostridium colitis:

Browse all the conditions that are associated with Clostridium colitis:


How the study uses the data?

The study uses data from the FDA. It is based on doxorubicin hydrochloride (the active ingredients of Doxorubicin hydrochloride) and Doxorubicin hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: